ClinicalTrialsFinder

Multiple Myeloma and Other Plasma Cell Neoplasms Clinical Trials in Suzhou, Jiangsu

1 recruitingSuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Other Plasma Cell Neoplasms
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.15 enrolled5 locationsNCT07529782